Northside Hospital Research Program

Find Open Clinical Trials

Return to Search

Phase III Study of Daratumumab/rHuPH20 (NSC- 810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT04071457
Protocol Number
C-389
Phase
III
Management Group
BMT Program
Oncology Group
BMT Oncology Group
Disease Sites
Multiple Myeloma
Sponsor Protocol
S1803
Principal Investigator
Asad Bashey
Scope
National
Participating Institutions
Northside Hospital - Atlanta (BMT)
Return to Search

Want to learn more?

For further information on our clinical trials, please call the Northside Hospital Research Program at (404) 303-3355 or

Email Us

For further information on our clinical trials, please contact the Northside Hospital Research Program at
(404) 303-3355 or

Call Us
Email Us